Cardlytics (NASDAQ:CDLX) CEO Amit Gupta Sells 52,049 Shares

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 52,049 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $0.90, for a total value of $46,844.10. Following the transaction, the chief executive officer owned 704,803 shares in the company, valued at approximately $634,322.70. This represents a 6.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Amit Gupta also recently made the following trade(s):

• On Wednesday, February 18th, Amit Gupta sold 45,159 shares of Cardlytics stock. The stock was sold at an average price of $0.93, for a total value of $41,997.87.
• On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The stock was sold at an average price of $1.17, for a total value of $6,794.19.

Cardlytics Stock Up 2.2%

Shares of CDLX opened at $0.93 on Thursday. Cardlytics, Inc. has a 52-week low of $0.80 and a 52-week high of $3.33. The company has a market capitalization of $50.35 million, a PE ratio of -0.44, a price-to-earnings-growth ratio of 0.14 and a beta of 1.03. The stock has a fifty day simple moving average of $1.10 and a two-hundred day simple moving average of $1.40. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 2.87.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Wall Street Zen downgraded Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Three investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce” and a consensus price target of $2.25.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Barclays PLC boosted its position in shares of Cardlytics by 31,167.6% during the fourth quarter. Barclays PLC now owns 55,969 shares of the company’s stock worth $64,000 after buying an additional 55,790 shares during the period. Renaissance Technologies LLC purchased a new position in Cardlytics during the 4th quarter valued at about $62,000. Goldman Sachs Group Inc. grew its position in Cardlytics by 15.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after acquiring an additional 14,273 shares in the last quarter. Geode Capital Management LLC grew its position in Cardlytics by 3.3% in the 4th quarter. Geode Capital Management LLC now owns 654,472 shares of the company’s stock valued at $753,000 after acquiring an additional 20,908 shares in the last quarter. Finally, Sender Co & Partners Inc. purchased a new stake in Cardlytics during the third quarter worth about $210,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.